Smad2 Activators
The chemical class known as Smad2 Activators encompasses a diverse group of compounds that indirectly influence the activity of Smad2, a protein integral to the cellular signaling pathways. Smad2, primarily activated through the Transforming Growth Factor-beta (TGF-β) signaling pathway, plays a crucial role in regulating various cellular functions, including proliferation and differentiation. The activators within this class do not directly bind to Smad2; instead, they modulate its activity by interacting with upstream elements of the TGF-β signaling pathway or related processes. This interaction often involves the inhibition or alteration of kinases and receptors that are part of the TGF-β pathway, thereby leading to a cascade of events that culminate in the activation of Smad2. The chemicals in this class are characterized by their diverse structures and mechanisms of action, ranging from small molecule inhibitors to larger biochemical entities.
The uniqueness of this chemical class lies in its indirect approach to modulating a specific protein function. By targeting the TGF-β signaling pathway, these compounds indirectly influence the phosphorylation and subsequent activation of Smad2. This mechanism of action is critical because it allows for the modulation of Smad2 activity without the need for direct interaction with the protein itself, which can be challenging due to the protein's structure and the complexity of its activation mechanisms. The compounds vary in their specificity and potency, with some showing a more targeted effect on the TGF-β pathway, while others have broader biological activities that indirectly affect Smad2. This indirect modulation is key to the functioning of these compounds, as it enables the regulation of Smad2 activity, a critical factor in numerous cellular processes. The Smad2 Activators therefore represent a significant chemical class, not only for their unique mechanism of action but also for their role in modulating a pathway that is central to a wide range of cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
D4476 is a potent inhibitor of TGF-β type I receptor ALK5. While primarily known as an inhibitor, its potential role as an activator arises from its ability to modulate TGF-β signaling, impacting Smad2 activation. It influences the TGF-β pathway by preventing ALK5-mediated phosphorylation of Smad2, providing a unique avenue for investigating dual roles of compounds in inhibiting and indirectly activating Smad2. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189, an inhibitor of BMP type I receptors, could indirectly impact Smad2 activation. By altering the balance of BMP signaling, LDN-193189 may influence the crosstalk between BMP and TGF-β pathways, affecting Smad2 phosphorylation. This compound offers a unique avenue to explore the intricate network of signaling pathways and their potential convergence points, shedding light on the multifaceted regulation of Smad2 in cellular processes. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin, known for inhibiting BMP signaling, could indirectly activate Smad2 by disrupting the inhibitory influence of BMP signaling on the TGF-β pathway. Through its impact on BMP receptors, Dorsomorphin may lead to enhanced Smad2 activation, illustrating the interconnectedness of distinct signaling cascades in fine-tuning Smad2 dynamics. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $102.00 $416.00 | 6 | |
Antifibrotic agent that may indirectly modulate Smad2 through TGF-β pathway interference. | ||||||
IN-1130 | 868612-83-3 | sc-507462 | 25 mg | $435.00 | ||
IN-1130, an ALK5 inhibitor, may exhibit dual functionality by influencing Smad2 activation indirectly. While primarily recognized as an inhibitor, its impact on ALK5-mediated events within the TGF-β pathway suggests potential pathways for Smad2 activation. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $31.00 $103.00 $283.00 $978.00 | 2 | |
Anti-allergic drug, possibly influencing Smad2 activity via TGF-β pathway modulation. | ||||||